DoW Lung Cancer Translational Research Award
Danielle Reckley Grantor is funding science & technology projects through this opportunity, which is open to eligible applicants, with applications due Sep 2, 2026.
Apply on Grants.govOpportunity description
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis.
Distinctive Features: This funding mechanism intends to support a broad range of translational studies and allows application submission under: Funding Level 1 – Advanced/late-stage preclinical work or correlative studies; or Funding Level 2 – Pilot clinical trials of novel interventions.
Who can apply
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Agency contact
How to apply
This award is administered through the federal Grants.gov system. Review the complete instructions and verify the deadline on the official page before starting your submission.
Official Grants.gov listingWe summarize this opportunity from the public Grants.gov database for convenience. It is general information, not legal or grant advice. VolunteerBadge is not affiliated with any agency — rely on the official listing for final details and deadlines.